208 related articles for article (PubMed ID: 31994732)
1. Putative promoters within gene bodies control exon expression via TET1-mediated H3K36 methylation.
Ma L; Muhammad T; Wang H; Du G; Sakhawat A; Wei Y; Ali Khan A; Cong X; Huang Y
J Cell Physiol; 2020 Oct; 235(10):6711-6724. PubMed ID: 31994732
[TBL] [Abstract][Full Text] [Related]
2. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
[TBL] [Abstract][Full Text] [Related]
3. GADD45A binds R-loops and recruits TET1 to CpG island promoters.
Arab K; Karaulanov E; Musheev M; Trnka P; Schäfer A; Grummt I; Niehrs C
Nat Genet; 2019 Feb; 51(2):217-223. PubMed ID: 30617255
[TBL] [Abstract][Full Text] [Related]
4. Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver Cancer.
Thomson JP; Ottaviano R; Unterberger EB; Lempiäinen H; Muller A; Terranova R; Illingworth RS; Webb S; Kerr AR; Lyall MJ; Drake AJ; Wolf CR; Moggs JG; Schwarz M; Meehan RR
Cancer Res; 2016 May; 76(10):3097-108. PubMed ID: 27197233
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter.
Han H; Cortez CC; Yang X; Nichols PW; Jones PA; Liang G
Hum Mol Genet; 2011 Nov; 20(22):4299-310. PubMed ID: 21835883
[TBL] [Abstract][Full Text] [Related]
6. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
7. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
Müller I; Wischnewski F; Pantel K; Schwarzenbach H
BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease.
Jeziorska DM; Murray RJS; De Gobbi M; Gaentzsch R; Garrick D; Ayyub H; Chen T; Li E; Telenius J; Lynch M; Graham B; Smith AJH; Lund JN; Hughes JR; Higgs DR; Tufarelli C
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):E7526-E7535. PubMed ID: 28827334
[TBL] [Abstract][Full Text] [Related]
9. TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.
Kai M; Niinuma T; Kitajima H; Yamamoto E; Harada T; Aoki H; Maruyama R; Toyota M; Sasaki Y; Sugai T; Tokino T; Nakase H; Suzuki H
PLoS One; 2016; 11(12):e0168281. PubMed ID: 27977763
[TBL] [Abstract][Full Text] [Related]
10. Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2.
Li M; Tang Y; Li Q; Xiao M; Yang Y; Wang Y
Oncogene; 2019 May; 38(18):3488-3503. PubMed ID: 30651599
[TBL] [Abstract][Full Text] [Related]
11. Contrasting chromatin organization of CpG islands and exons in the human genome.
Choi JK
Genome Biol; 2010; 11(7):R70. PubMed ID: 20602769
[TBL] [Abstract][Full Text] [Related]
12. Targeted TET oxidase activity through methyl-CpG-binding domain extensively suppresses cancer cell proliferation.
Mizuguchi Y; Saiki Y; Horii A; Fukushige S
Cancer Med; 2016 Sep; 5(9):2522-33. PubMed ID: 27457352
[TBL] [Abstract][Full Text] [Related]
13. Understanding the interplay between CpG island-associated gene promoters and H3K4 methylation.
Hughes AL; Kelley JR; Klose RJ
Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194567. PubMed ID: 32360393
[TBL] [Abstract][Full Text] [Related]
14. Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer.
Umeh-Garcia M; O'Geen H; Simion C; Gephart MH; Segal DJ; Sweeney CA
Br J Cancer; 2022 Aug; 127(3):436-448. PubMed ID: 35440669
[TBL] [Abstract][Full Text] [Related]
15. Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells.
Bakker J; Lin X; Nelson WG
J Biol Chem; 2002 Jun; 277(25):22573-80. PubMed ID: 11960994
[TBL] [Abstract][Full Text] [Related]
16. A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer.
Good CR; Madzo J; Patel B; Maegawa S; Engel N; Jelinek J; Issa JJ
Nucleic Acids Res; 2017 Aug; 45(14):8269-8281. PubMed ID: 28531272
[TBL] [Abstract][Full Text] [Related]
17. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
18. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
Kondo Y; Shen L; Cheng AS; Ahmed S; Boumber Y; Charo C; Yamochi T; Urano T; Furukawa K; Kwabi-Addo B; Gold DL; Sekido Y; Huang TH; Issa JP
Nat Genet; 2008 Jun; 40(6):741-50. PubMed ID: 18488029
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
Vaidya H; Rumph C; Katula KS
PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
[TBL] [Abstract][Full Text] [Related]
20. DNA Methylation of Intragenic CpG Islands are Required for Differentiation from iPSC to NPC.
Choi WY; Hwang JH; Cho AN; Lee AJ; Lee J; Jung I; Cho SW; Kim LK; Kim YJ
Stem Cell Rev Rep; 2020 Dec; 16(6):1316-1327. PubMed ID: 32975781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
